HVAD Is Off the Market—Now What?

Following the market removal of the HeartWare Ventricular Assist Device (HVAD) system, surgeons and industry representatives from the US and Europe discuss patient care implications, including new data from the Intermacs Database on survival benefits from a device exchange. The latest episode of the STS Webinar Series is presented in conjunction with the International Society for Heart and Lung Transplantation.

Francis D. Pagani, MD, PhD
Michigan Medicine, University of Michigan
Ann Arbor, MI

Jennifer A. Cowger, MD, MS
Henry Ford Health System
Detroit, MI

A. Pieter Kappetein, MD, PhD
Rotterdam, Netherlands
Arman Kilic, MD
Medical University of South Carolina
Charleston, SC
Robert L. Kormos, MD, FRCSC
Austin, TX
Nahush A. Mokadam, MD
The Ohio State University Wexner Medical Center
Columbus, OH
Diyar Saeed, MD, PhD
Leipzig Heart Center
Leipzig, Germany